Stanley Druckenmiller
MDCO

Stanley Druckenmiller’s Medicines Co MDCO Stock Holding History

Stanley Druckenmiller’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-585,500
Closed -$49.7M – 71
2019
Q4 		$49.7M Hold
585,500
– – 1.46% 22
2019
Q3 		$29.3M Buy
+585,500
New +$23.4M 1.14% 22

Other funds holding MDCO

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Stanley Druckenmiller's MDCO Position: Q1 2020 in Review

Stanley Druckenmiller sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 585,500 shares — an estimated $49.7M sold.

Stanley Druckenmiller first reported a position in MDCO in Q3 2019 and held it in 2 quarters. The position peaked at $49.7M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

  • Stanley Druckenmiller reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
  • Stanley Druckenmiller sold 585,500 Medicines Co shares in Q1 2020, an estimated $49.7M.
  • Stanley Druckenmiller first reported a position in Medicines Co in Q3 2019 and held it in 2 quarters.
  • Stanley Druckenmiller's Medicines Co position peaked at $49.7M in Q4 2019.
  • 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Duquesne Family Office's 13F filing for Q1 2020, filed 15 May 2020.